We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+12.43%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.03B
AUM Growth
+$589M
Cap. Flow
+$81.4M
Cap. Flow %
1.35%
Top 10 Hldgs %
18.86%
Holding
1,529
New
146
Increased
642
Reduced
570
Closed
93

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Financials 10.31%
3 Industrials 8.91%
4 Healthcare 8.6%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUB icon
1326
Atlantic Union Bankshares
AUB
$6.02B
$209K ﹤0.01%
5,916
-450
-7% -$15.5K
RZV icon
1327
Invesco S&P SmallCap 600 Pure Value ETF
RZV
$290M
$209K ﹤0.01%
1,943
-46
-2% -$4.74K
TRVI icon
1328
Trevi Therapeutics
TRVI
$2.59B
$208K ﹤0.01%
+60,415
New +$135K
ONON icon
1329
On Holding
ONON
$12.1B
$208K ﹤0.01%
+5,882
New +$180K
CMF icon
1330
iShares California Muni Bond ETF
CMF
$4.55B
$207K ﹤0.01%
3,595
-1,925
-35% -$111K
SPHB icon
1331
Invesco S&P 500 High Beta ETF
SPHB
$971M
$207K ﹤0.01%
2,356
-272
-10% -$22.5K
HYS icon
1332
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
$206K ﹤0.01%
2,205
-499
-18% -$46.5K
EUM icon
1333
ProShares Trust Short MSCI Emerging Markets
EUM
$9.65M
$206K ﹤0.01%
7,375
-24,734
-77% -$714K
APLS
1334
DELISTED
Apellis Pharmaceuticals
APLS
$206K ﹤0.01%
3,500
-8,730
-71% -$556K
UTL icon
1335
Unitil
UTL
$970M
$205K ﹤0.01%
3,925
GTLS.PRB
1336
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
$205K ﹤0.01%
+3,200
New +$176K
BMEA icon
1337
Biomea Fusion
BMEA
$84.6M
$205K ﹤0.01%
13,704
-11,658
-46% -$192K
GPI icon
1338
Group 1 Automotive
GPI
$3.42B
$205K ﹤0.01%
+701
New +$192K
ONTO icon
1339
Onto Innovation
ONTO
$12.9B
$204K ﹤0.01%
+1,125
New +$190K
JLL icon
1340
Jones Lang LaSalle
JLL
$16.3B
$203K ﹤0.01%
+1,040
New +$189K
JRI icon
1341
Nuveen Real Asset Income & Growth Fund
JRI
$356M
$202K ﹤0.01%
17,050
+1,017
+6% +$11.8K
MSCI icon
1342
MSCI
MSCI
$41.6B
$201K ﹤0.01%
359
+3
+0.8% +$1.69K
WRB icon
1343
W.R. Berkley
WRB
$26.9B
$201K ﹤0.01%
+3,413
New +$185K
FDS icon
1344
Factset
FDS
$9.36B
$201K ﹤0.01%
442
+9
+2% +$4.2K
TU icon
1345
Telus
TU
$14.9B
$199K ﹤0.01%
12,460
-898
-7% -$15.7K
WT icon
1346
WisdomTree
WT
$2.96B
$198K ﹤0.01%
+21,500
New +$165K
CHY
1347
Calamos Convertible and High Income Fund
CHY
$1.01B
$193K ﹤0.01%
16,375
+4,629
+39% +$54.6K
GBDC icon
1348
Golub Capital BDC
GBDC
$3.34B
$192K ﹤0.01%
11,571
-920
-7% -$14.4K
FTF
1349
Franklin Limited Duration Income Trust
FTF
$231M
$192K ﹤0.01%
30,545
+395
+1% +$2.49K
TEVA icon
1350
Teva Pharmaceuticals
TEVA
$40.8B
$191K ﹤0.01%
13,522
+1,180
+10% +$14.9K

Similar funds

Oppenheimer & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Oppenheimer & Co held 1,529 positions worth $6.03B, up 11% from $5.44B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oppenheimer & Co's Q1 2024 filing shows 146 new, 642 increased, 570 reduced and 93 closed positions. Its largest new stake was State Street SPDR Portfolio Long Term Treasury ETF: 116,262 shares worth $3.25M. The largest sale was NVIDIA, an estimated $8.83M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q1 2024 buy was State Street SPDR Portfolio Long Term Treasury ETF: 116,262 shares worth $3.25M.
  • Oppenheimer & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $7.26M increase.
  • Oppenheimer & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $8.83M.
  • Oppenheimer & Co fully exited Pacer Developed Markets International Cash Cows 100 ETF in Q1 2024, selling an estimated $2.89M.
  • Oppenheimer & Co's ten largest holdings make up 19% of its $6.03B portfolio in Q1 2024.
  • Oppenheimer & Co opened 146 new positions and closed 93 in Q1 2024.
  • Oppenheimer & Co's portfolio value rose 11% quarter-over-quarter to $6.03B.

Based on Oppenheimer & Co's 13F filing for Q1 2024, filed 7 May 2024.